Steroid-induced myopathy is a rare condition defined as gradually increasin
g muscle weakness in a patient on glucocorticoid therapy. All glucocorticoi
ds, including fluorinated derivatives, have been incriminated. The clinical
spectrum ranges from muscle fatigability to diffuse myopathy. Two cases ar
e reported, in a 48-year-old man with rheumatoid arthritis and sicca syndro
me and a 60-year-old woman with anterior pituitary insufficiency. Electrodi
agnostic testing confirmed the myopathy. In the woman, histological feature
s were consistent with the diagnosis. Laboratory test results were those ex
pected in rheumatoid arthritis in the man and were normal in the woman. Fol
lowing substitution of methylprednisolone for the hydrocortisone used forme
rly, the muscle weakness resolved fully in both patients. Steroid-induced m
yopathy is a rare condition that has a favorable outcome after hydrocortiso
ne substitution. Its pathophysiology may involve cytochrome 450 production
within skeletal muscles.